KRISTEN LOOMAN: Open Payments
NPI 1205400439 · BRIGHTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$646 in 26 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $31 · 2025 $646
Food & beverage: $534Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $159 |
| Otsuka America Pharmaceutical, Inc. | 5 | $116 |
| Axsome Therapeutics, Inc. | 6 | $110 |
| Corium, LLC | 3 | $72 |
| E.R. Squibb & Sons, L.L.C. | 2 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $46 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
| ABBVIE INC. | 2 | $34 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
Products named: REXULTI, Auvelity, Azstarys, COBENFY, UZEDY, TRINTELLIX, CAPLYTA, VRAYLAR.
Industry payments across MA — which companies pay providers there.
